The global compounded topical drug market is projected to grow from US$ 4.3 billion in 2024 to US$ 6.8 billion by 2034, with a CAGR of 4.7% during the forecast period. In 2024, North America led the market with a 39.8% share, generating over US$ 1.7 billion in revenue. This growth is largely driven by the rising prevalence of chronic skin conditions such as eczema, dermatitis, and psoriasis....
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek